ibutilide has been researched along with Myocardial Ischemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gonzalez, MD; Sendra-Ferrer, M | 1 |
| Elnabtity, M; Fromm, BS; Lavine, SJ; Lehmann, MH; Meissner, MD; Munir, A; Nabih, MA; Prcevski, P; Steinman, RT | 1 |
| Henderson, C; Kane, K; Tweedie, D | 1 |
3 other study(ies) available for ibutilide and Myocardial Ischemia
| Article | Year |
|---|---|
Ibutilide for the control of refractory ventricular tachycardia and ventricular fibrillation in patients with myocardial ischemia and hemodynamic instability.
Topics: Administration, Intravenous; Aged; Anti-Arrhythmia Agents; Electric Countershock; Extracorporeal Membrane Oxygenation; Female; Heart-Assist Devices; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardial Revascularization; Sulfonamides; Tachycardia, Ventricular; Time Factors; Treatment Outcome; Ventricular Fibrillation; Ventricular Function, Left | 2019 |
Effect of ibutilide, a new class III agent, on sustained atrial fibrillation in a canine model of acute ischemia and myocardial dysfunction induced by microembolization.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease Models, Animal; Dogs; Infusions, Intravenous; Injections, Intravenous; Myocardial Ischemia; Sulfonamides; Time Factors; Ventricular Function, Left | 1993 |
Glibenclamide, but not class III drugs, prevents ischaemic shortening of the refractory period in guinea-pig hearts.
Topics: Analysis of Variance; Animals; Anti-Arrhythmia Agents; Coronary Circulation; Electrocardiography; Glyburide; Guinea Pigs; Heart; Male; Myocardial Ischemia; Phenethylamines; Phentolamine; Pyrazines; Pyridines; Refractory Period, Electrophysiological; Sulfonamides; Temperature | 1993 |